Gut dysbiosis has been associated with inflammatory bowel disease (IBD), one of the most
common gastrointestinal diseases. The microbial communities play essential roles in host …

Clostridioides difficile infection is a leading cause of healthcare-associated infections with
significant morbidity and mortality. For the past decade, the bulk of infection prevention and …

The introduction and broad use of new immunosuppressive agents, including biologic
agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease …

Clostridioides difficile infection occurs when the bacterium produces toxin that causes
diarrhea and inflammation of the colon. These guidelines indicate the preferred approach to …

Im Jahr 2019 wurden etwa 25 500 Patient* innen mit M. Crohn im Krankenhaus stationär
behandelt [1]. Meistens tritt die Erkrankung in der Adoleszenz und im jungen …

Approximately 10% of individuals diagnosed with Clostridium difficile infection (CDI) show
the resistance to fecal microbiota transplantation (FMT), with the underlying mechanisms …

Immune checkpoint inhibitors (ICIs) have revolutionised cancer treatment. However, immune-
related adverse events (irAEs) are a common side effect which can mimic infection …

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) with chronic and recurrent
characteristics caused by multiple reasons. Although the pathogenic factors have not been …

Objective To evaluate the risk of common infections in individuals with inflammatory bowel
disease (IBD)[ulcerative colitis and Crohn's disease] compared with matched controls in a …

Inflammasome targeting and controlling dysbiosis are promising therapeutic approaches to
control ulcerative colitis. This report is the first to investigate the mechanisms underlying the …